ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 322,87
-0,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioMarin Pharmaceutical Inc (BMRN)

  7. BioMarin Pharmaceutical Inc (BMRN) Actualités

BMRN BioMarin Pharmaceutical Inc

83,70
2,85 (3,53%)
08 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BioMarin Pharmaceutical Inc BMRN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
2,85 3,53% 83,70 06:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
80,665 80,31 81,47 80,69 80,85
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/6/202400:09PRNUSKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500;..
07/6/202415:00PRNUSBioMarin Presents New Phase 3, Four-Year Data Underscoring..
05/6/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202416:18EDGAR2Form 144 - Report of proposed sale of securities
01/6/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202416:49EDGAR2Form 144 - Report of proposed sale of securities
31/5/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202420:22EDGAR2Form 144 - Report of proposed sale of securities
30/5/202416:18EDGAR2Form 144 - Report of proposed sale of securities
30/5/202416:10EDGAR2Form 144 - Report of proposed sale of securities
29/5/202416:28EDGAR2Form 144 - Report of proposed sale of securities
28/5/202416:36EDGAR2Form 144 - Report of proposed sale of securities
24/5/202422:02EDGAR2Form 8-K - Current report
23/5/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/5/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202423:16EDGAR2Form 8-K - Current report
13/5/202421:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202416:11EDGAR2Form 144 - Report of proposed sale of securities
09/5/202416:54EDGAR2Form 144 - Report of proposed sale of securities
08/5/202414:00PRNUSBioMarin to Present at the BofA Securities 2024 Health Care..
07/5/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/5/202422:00PRNUSNew Data for BioMarin's VOXZOGO® (vosoritide) for Multiple..
24/4/202422:03PRNUSBioMarin Reports Record Financial Results for the First..
10/4/202414:00PRNUSBioMarin to Host First Quarter 2024 Financial Results..
12/3/202413:30PRNUSNew Data to be Presented for BioMarin's VOXZOGO®..
08/3/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:30PRNUSBioMarin Announces Appointment of Cristin Hubbard as Chief..
06/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:17EDGAR2Form 144 - Report of proposed sale of securities
05/3/202420:41EDGAR2Form 144 - Report of proposed sale of securities
05/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:00PRNUSBioMarin Scheduled to Participate in March Investor..
29/2/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
BMRN
BioMarin Pharmaceutical
LSE
ZI77
Cred Ag Co 30
USOTC
ALFNF
Alfen NV (PK)
USOTC
OTSTS
Otis Gallery (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés